FDA-Guided Study Finds No Paclitaxel Death Risk In Medicare Patients
Executive Summary
The SAFE-PAD study, which looked at data from more than 168,000 Medicare beneficiaries, found a slightly lower death rate in patients treated with drug-coated balloons and stents than those who were not.